Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Vascular smooth muscle contraction (mmu04270)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Acta2
KLA  ATP  ATP+KLA
 AK033744 adult male epididymis cDNA, RIKEN full-length enriched library, clone:9230101E03 product:Actin, full insert sequence [AK033744] KLA 1.05 1.06 1.07 1.01 1.09 1.02 .95
ATP 1.05 1.01 1.03 1.04 .95 1.03 1.13
KLA/ATP .98 .94 1.08 .99 1.06 .99 1.08
Acta2
KLA  ATP  ATP+KLA
 NM_007392 actin, alpha 2, smooth muscle, aorta (Acta2), mRNA [NM_007392] KLA 1.20 1.21 1.37 1.41 1.22 1.16 1.05
ATP .98 1.03 1.33 1.57 1.30 1.50 1.46
KLA/ATP 1.25 1.36 1.79 2.08 1.77 1.48 1.87
Actg2
KLA  ATP  ATP+KLA
 NM_009610 actin, gamma 2, smooth muscle, enteric (Actg2), mRNA [NM_009610] KLA 1.22 1.32 1.28 1.37 1.70 2.41 1.66
ATP .94 1.16 .84 1.40 .93 .62 .88
KLA/ATP 1.28 1.40 1.06 1.89 1.15 1.22 1.05
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adm
KLA  ATP  ATP+KLA
 NM_009627 adrenomedullin (Adm), mRNA [NM_009627] KLA 2.86 2.42 2.38 2.00 1.58 1.28 1.20
ATP 1.00 1.04 1.90 6.55 8.74 6.32 1.29
KLA/ATP 2.81 2.95 3.07 4.93 5.99 3.27 1.44
Adora2a
KLA  ATP  ATP+KLA
 NM_009630 adenosine A2a receptor (Adora2a), mRNA [NM_009630] KLA 9.23 9.88 9.08 9.21 9.36 7.45 8.23
ATP 1.09 1.01 1.36 2.05 4.26 8.29 1.91
KLA/ATP 9.17 11.00 9.06 9.28 10.88 11.46 9.73
Adora2b
KLA  ATP  ATP+KLA
 NM_007413 adenosine A2b receptor (Adora2b), mRNA [NM_007413] KLA 2.50 3.09 4.71 7.11 7.38 4.18 3.17
ATP .98 1.02 1.16 4.52 8.81 7.95 2.66
KLA/ATP 2.56 3.38 4.49 5.78 7.34 7.41 6.23
Adra1a
KLA  ATP  ATP+KLA
 NM_013461 adrenergic receptor, alpha 1a (Adra1a), mRNA [NM_013461] KLA .78 .74 .75 .85 .96 1.37 2.70
ATP 1.05 1.14 .97 .97 1.69 1.06 2.56
KLA/ATP .76 .75 .83 .84 1.51 1.34 4.08
Adra1b
KLA  ATP  ATP+KLA
 NM_007416 adrenergic receptor, alpha 1b (Adra1b), mRNA [NM_007416] KLA 1.04 .99 .98 1.02 .99 1.00 1.01
ATP 1.00 .99 .98 1.01 1.06 1.01 1.05
KLA/ATP .99 .97 1.03 1.03 1.00 .97 1.08
Adra1d
KLA  ATP  ATP+KLA
 NM_013460 adrenergic receptor, alpha 1d (Adra1d), mRNA [NM_013460] KLA 1.13 1.12 1.21 1.25 1.30 1.34 1.27
ATP 1.02 .99 1.16 1.08 1.13 1.11 1.06
KLA/ATP 1.15 1.10 1.20 1.14 1.24 1.16 1.13
Agt
KLA  ATP  ATP+KLA
 NM_007428 angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (Agt), mRNA [NM_007428] KLA .99 .98 1.02 1.04 1.00 .96 1.07
ATP .95 .95 .99 .99 .98 1.02 1.03
KLA/ATP .96 1.00 .99 .97 1.00 1.02 1.02
Agtr1a
KLA  ATP  ATP+KLA
 NM_177322 angiotensin II receptor, type 1a (Agtr1a), mRNA [NM_177322] KLA 1.04 1.00 1.00 1.03 1.03 .95 1.00
ATP .98 .99 1.00 1.00 .95 1.05 1.06
KLA/ATP 1.00 .97 1.03 .97 .99 .96 .98
Agtr1b
KLA  ATP  ATP+KLA
 NM_175086 angiotensin II receptor, type 1b (Agtr1b), mRNA [NM_175086] KLA 1.02 .94 1.04 1.01 1.01 1.00 .95
ATP .97 1.01 1.03 .95 .98 1.09 1.02
KLA/ATP .94 .99 .99 .97 .99 .95 1.12
AK037826
KLA  ATP  ATP+KLA
 AK037826 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130052M19 product:unclassifiable, full insert sequence. [AK037826] KLA .99 1.08 1.02 1.02 .98 1.02 1.02
ATP .98 1.02 .99 1.05 1.00 1.02 1.01
KLA/ATP 1.06 1.01 .96 1.00 1.00 1.04 1.03
Araf
KLA  ATP  ATP+KLA
 NM_009703 v-raf murine sarcoma 3611 viral oncogene homolog (Araf), mRNA [NM_009703] KLA .87 .80 .89 .93 1.10 1.19 1.16
ATP 1.09 1.11 1.19 1.18 .78 .53 1.18
KLA/ATP 1.00 .95 .99 .93 .63 .55 1.27
Arhgef1
KLA  ATP  ATP+KLA
 NM_008488 Rho guanine nucleotide exchange factor (GEF) 1 (Arhgef1), mRNA [NM_008488] KLA .80 .82 .80 .56 .66 .74 .85
ATP 1.19 1.53 .87 1.47 .87 .55 .84
KLA/ATP 1.07 .88 .51 .99 .50 .58 .65
Arhgef11
KLA  ATP  ATP+KLA
 NM_001003912 Rho guanine nucleotide exchange factor (GEF) 11 (Arhgef11), mRNA [NM_001003912] KLA .90 .95 .96 .88 .93 .92 1.01
ATP 1.07 1.19 1.00 1.25 .82 .82 .99
KLA/ATP .99 1.03 .83 .96 .78 .89 .98
Arhgef12
KLA  ATP  ATP+KLA
 NM_027144 Rho guanine nucleotide exchange factor (GEF) 12 (Arhgef12), mRNA [NM_027144] KLA 1.01 .94 .89 .87 .84 .81 .80
ATP 1.05 .94 1.09 .77 .60 .86 .78
KLA/ATP .93 .88 .86 .70 .52 .66 .58
Avp
KLA  ATP  ATP+KLA
 NM_009732 arginine vasopressin (Avp), mRNA [NM_009732] KLA .98 .99 1.04 1.02 1.03 1.09 1.05
ATP 1.02 1.06 1.03 .99 1.01 1.01 1.08
KLA/ATP 1.00 1.02 1.10 1.01 .99 1.02 1.02
Avpr1a
KLA  ATP  ATP+KLA
 NM_016847 arginine vasopressin receptor 1A (Avpr1a), mRNA [NM_016847] KLA 1.00 1.07 .95 .99 1.01 1.01 1.00
ATP .99 .94 1.01 1.08 1.01 1.06 .99
KLA/ATP 1.10 .98 1.04 1.00 .99 1.05 1.00
Avpr1b
KLA  ATP  ATP+KLA
 NM_011924 arginine vasopressin receptor 1B (Avpr1b), mRNA [NM_011924] KLA 1.01 .93 .97 1.03 1.00 .97 1.01
ATP .99 1.02 1.05 1.03 1.01 1.04 1.06
KLA/ATP .93 1.00 .97 .97 .92 .96 1.04
Braf
KLA  ATP  ATP+KLA
 NM_139294 Braf transforming gene (Braf), mRNA [NM_139294] KLA 1.52 1.57 1.55 1.33 1.83 1.52 1.60
ATP 1.08 1.17 1.02 1.37 .95 1.15 .95
KLA/ATP 1.64 1.69 1.39 1.51 1.04 1.31 1.26
Cacna1d
KLA  ATP  ATP+KLA
 NM_001083616 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] KLA 1.57 1.58 2.50 3.62 4.55 2.93 .99
ATP 1.12 .99 .97 .94 .75 1.71 1.48
KLA/ATP 1.47 1.51 1.82 1.56 1.67 2.93 4.60
Cacna1d
KLA  ATP  ATP+KLA
 NM_028981 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] KLA 1.20 1.26 1.43 1.62 2.07 1.66 1.00
ATP 1.03 1.03 .97 .97 .93 1.20 1.26
KLA/ATP 1.16 1.12 1.10 1.14 1.08 1.44 2.56
Cacna1f
KLA  ATP  ATP+KLA
 NM_019582 calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] KLA 1.03 .98 1.05 1.06 1.00 1.02 1.01
ATP 1.05 1.05 .95 .98 .97 .96 1.01
KLA/ATP 1.01 1.03 .94 1.01 1.01 1.00 .99
Cacna1s
KLA  ATP  ATP+KLA
 NM_001081023 calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] KLA 1.03 1.01 .96 1.06 1.00 1.00 1.05
ATP 1.01 .98 1.02 1.02 1.05 1.07 1.05
KLA/ATP .99 1.05 1.02 1.05 1.03 1.05 1.00
Calcrl
KLA  ATP  ATP+KLA
 NM_018782 calcitonin receptor-like (Calcrl), mRNA [NM_018782] KLA 3.33 3.29 2.57 2.69 1.56 .90 1.22
ATP .93 .86 .80 .77 .85 1.39 .79
KLA/ATP 2.95 2.86 1.96 1.75 1.26 .78 .79
Cald1
KLA  ATP  ATP+KLA
 NM_145575 caldesmon 1 (Cald1), mRNA [NM_145575] KLA .99 1.05 .94 .93 .94 .94 .91
ATP 1.01 1.02 .94 1.04 .97 .93 .95
KLA/ATP 1.01 .98 .94 .98 .90 .96 .92
Calm1
KLA  ATP  ATP+KLA
 NM_009790 calmodulin 1 (Calm1), mRNA [NM_009790] KLA 1.20 1.26 1.30 1.06 1.16 1.09 1.18
ATP 1.07 1.20 1.00 1.29 .99 .64 .58
KLA/ATP 1.31 1.31 .93 1.31 .97 .83 .59
Calm2
KLA  ATP  ATP+KLA
 NM_007589 calmodulin 2 (Calm2), mRNA [NM_007589] KLA .79 .81 .71 .67 .54 .45 .64
ATP .99 1.03 1.04 .93 .82 .52 .76
KLA/ATP .76 .78 .76 .77 .73 .47 .42
Calm3
KLA  ATP  ATP+KLA
 NM_007590 calmodulin 3 (Calm3), mRNA [NM_007590] KLA .95 .96 .93 1.03 1.05 1.08 1.00
ATP .93 .96 .99 .97 .93 .84 .72
KLA/ATP .89 .93 .90 .91 1.02 .98 .70
Calm4
KLA  ATP  ATP+KLA
 NM_020036 calmodulin 4 (Calm4), mRNA [NM_020036] KLA 1.02 .96 1.05 1.00 .99 1.00 1.01
ATP 1.10 1.05 1.03 1.01 .94 .98 .98
KLA/ATP .99 1.12 1.01 1.03 .98 1.07 1.02
Calm5
KLA  ATP  ATP+KLA
 NM_001008706 calmodulin 5 (Calm5), mRNA [NM_001008706] KLA 1.02 1.11 .99 .98 1.07 1.01 1.09
ATP 1.07 1.05 1.04 1.04 1.01 1.04 .99
KLA/ATP 1.00 1.00 .97 1.07 1.00 1.07 .98
Calml3
KLA  ATP  ATP+KLA
 NM_027416 calmodulin-like 3 (Calml3), mRNA [NM_027416] KLA 1.01 .95 1.05 .91 1.01 .98 .89
ATP .91 1.05 1.04 1.01 .93 1.07 .99
KLA/ATP 1.01 .96 .97 .96 .97 .92 .99
Cyp4a10
KLA  ATP  ATP+KLA
 NM_010011 cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10), mRNA [NM_010011] KLA 1.14 1.13 1.13 1.13 1.15 1.12 1.06
ATP 1.02 1.01 1.09 1.03 1.10 1.11 1.00
KLA/ATP 1.09 1.11 1.36 1.23 1.25 1.09 1.02
Cyp4a10
KLA  ATP  ATP+KLA
 X71478 gb|M.musculus Cyp4a-10 mRNA. [X71478] KLA .94 .97 .93 1.01 1.01 1.09 1.26
ATP .96 1.07 1.04 1.18 .88 .77 1.18
KLA/ATP 1.00 .99 .98 .98 .84 .80 1.24
Cyp4a12a
KLA  ATP  ATP+KLA
 NM_177406 cytochrome P450, family 4, subfamily a, polypeptide 12a (Cyp4a12a), mRNA [NM_177406] KLA 1.08 1.04 1.02 1.06 .98 1.05 1.05
ATP .98 1.00 1.10 .99 .96 1.04 .98
KLA/ATP 1.07 1.05 1.11 .96 1.06 1.02 .97
Cyp4a12b
KLA  ATP  ATP+KLA
 NM_172306 cytochrome P450, family 4, subfamily a, polypeptide 12B (Cyp4a12b), mRNA [NM_172306] KLA 1.03 1.05 .95 .99 .94 1.02 1.12
ATP .93 .99 .95 1.00 .93 .95 1.01
KLA/ATP .98 1.01 1.09 1.00 .90 .91 .93
Cyp4a14
KLA  ATP  ATP+KLA
 NM_007822 cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14), mRNA [NM_007822] KLA .99 1.00 1.00 .97 .96 .97 1.01
ATP .95 .95 .93 .90 .93 .99 1.03
KLA/ATP .97 .99 1.04 .93 .95 .96 .97
Cyp4a29
KLA  ATP  ATP+KLA
 NM_001100183 cytochrome P450, family 4, subfamily a, polypeptide 29 (Cyp4a29), mRNA [NM_001100183] KLA .94 .98 1.04 1.00 .98 1.06 1.03
ATP 1.01 1.02 1.03 1.02 1.01 1.02 .97
KLA/ATP 1.05 1.09 1.03 1.03 .97 1.02 .91
Cyp4a31
KLA  ATP  ATP+KLA
 NM_201640 cytochrome P450, family 4, subfamily a, polypeptide 31 (Cyp4a31), mRNA [NM_201640] KLA 1.14 .99 1.00 .98 1.06 1.03 .96
ATP 1.01 1.05 1.04 .91 .98 .99 .99
KLA/ATP .99 1.03 1.04 .99 .95 .97 1.06
Edn1
KLA  ATP  ATP+KLA
 NM_010104 endothelin 1 (Edn1), mRNA [NM_010104] KLA 73.36 71.33 61.92 68.69 46.94 32.60 13.54
ATP 1.23 1.89 4.18 10.86 17.85 11.03 1.91
KLA/ATP 67.27 76.78 116.70 90.29 76.38 29.71 8.04
Edn2
KLA  ATP  ATP+KLA
 NM_007902 endothelin 2 (Edn2), mRNA [NM_007902] KLA 1.01 .97 1.01 1.04 1.03 1.03 1.09
ATP 1.03 1.06 .97 1.02 .98 .99 1.01
KLA/ATP 1.07 .99 .96 1.03 1.03 1.11 1.03
Edn3
KLA  ATP  ATP+KLA
 NM_007903 endothelin 3 (Edn3), mRNA [NM_007903] KLA .98 1.00 .99 1.00 .99 1.00 1.03
ATP .99 .99 .99 1.03 1.00 1.04 1.01
KLA/ATP 1.02 .97 1.00 1.06 .99 1.04 .99
Ednra
KLA  ATP  ATP+KLA
 AK042211 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630071G03 product:SIMILAR TO ENDOTHELIN RECEPTOR TYPE A, full insert sequence. [AK042211] KLA 1.00 1.03 1.03 .97 .98 .99 .99
ATP .96 .97 1.05 .95 1.05 1.04 1.02
KLA/ATP .99 .98 1.00 1.05 .97 .98 .83
Ednra
KLA  ATP  ATP+KLA
 NM_010332 endothelin receptor type A (Ednra), mRNA [NM_010332] KLA 1.06 .99 1.02 .91 1.05 1.00 .99
ATP 1.01 .98 1.03 .98 .98 1.03 1.06
KLA/ATP 1.01 1.06 1.04 .93 .92 .92 .97
Gna11
KLA  ATP  ATP+KLA
 NM_010301 guanine nucleotide binding protein, alpha 11 (Gna11), mRNA [NM_010301] KLA .62 .65 .69 .79 .94 1.00 .96
ATP 1.00 .94 .63 .53 .79 1.13 1.22
KLA/ATP .64 .60 .56 .55 .81 1.16 1.18
Gna12
KLA  ATP  ATP+KLA
 M63659 gb|Mouse G-alpha-12 protein mRNA, complete cds [M63659] KLA .48 .48 .49 .40 .44 .59 .60
ATP 1.08 1.15 1.00 1.39 1.02 .65 .73
KLA/ATP .52 .50 .51 .52 .56 .66 .52
Gna13
KLA  ATP  ATP+KLA
 NM_010303 guanine nucleotide binding protein, alpha 13 (Gna13), mRNA [NM_010303] KLA 1.96 2.10 2.12 1.85 2.36 2.02 1.54
ATP 1.04 1.13 1.19 3.56 6.50 2.32 1.44
KLA/ATP 2.17 2.07 1.67 3.72 6.89 3.91 2.27
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Gucy1a3
KLA  ATP  ATP+KLA
 NM_021896 guanylate cyclase 1, soluble, alpha 3 (Gucy1a3), mRNA [NM_021896] KLA 1.01 1.01 1.04 .99 .99 .97 .99
ATP .99 1.01 .99 .99 .97 1.02 1.02
KLA/ATP 1.00 .96 1.00 .99 .98 1.04 .99
Gucy1b2
KLA  ATP  ATP+KLA
 NM_172810 guanylate cyclase 1, soluble, beta 2 (Gucy1b2), mRNA [NM_172810] KLA 1.02 1.03 1.03 1.09 .95 1.06 .91
ATP 1.01 1.03 1.01 1.08 .96 1.04 .90
KLA/ATP 1.04 1.03 .99 1.05 .97 .96 .84
Gucy1b3
KLA  ATP  ATP+KLA
 NM_017469 guanylate cyclase 1, soluble, beta 3 (Gucy1b3), mRNA [NM_017469] KLA .99 .99 .99 1.01 .98 .98 1.00
ATP .98 .98 .98 .98 .98 1.00 1.01
KLA/ATP .96 .99 .98 1.01 .99 .99 .99
Itpr1
KLA  ATP  ATP+KLA
 NM_010585 inositol 1,4,5-triphosphate receptor 1 (Itpr1), mRNA [NM_010585] KLA 3.66 3.69 6.74 8.11 7.08 4.40 1.22
ATP 1.08 .95 1.19 .94 1.09 1.00 .68
KLA/ATP 3.48 3.58 5.86 6.03 4.01 2.31 .97
Itpr2
KLA  ATP  ATP+KLA
 NM_019923 inositol 1,4,5-triphosphate receptor 2 (Itpr2), transcript variant 1, mRNA [NM_019923] KLA 1.41 1.38 1.43 1.42 1.30 1.07 1.01
ATP 1.00 1.00 .97 .97 1.07 1.15 1.06
KLA/ATP 1.39 1.48 1.64 1.42 1.07 .83 .95
Itpr3
KLA  ATP  ATP+KLA
 NM_080553 inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] KLA .55 .51 .45 .41 .34 .34 .45
ATP 1.01 .92 1.02 .57 .46 .34 1.22
KLA/ATP .56 .48 .48 .29 .33 .27 .65
Kcnma1
KLA  ATP  ATP+KLA
 NM_010610 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (Kcnma1), mRNA [NM_010610] KLA 1.04 1.08 .96 .98 1.01 1.08 .96
ATP 1.03 .96 .99 .97 .98 .95 .99
KLA/ATP .99 1.07 1.04 1.04 .99 .95 .93
Kcnmb1
KLA  ATP  ATP+KLA
 AK039715 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330094H22 product:unclassifiable, full insert sequence [AK039715] KLA 1.09 .99 .98 1.03 1.02 1.06 1.02
ATP 1.03 1.04 1.03 1.01 .96 1.00 1.05
KLA/ATP 1.03 .98 .91 1.04 .98 1.04 1.03
Kcnmb1
KLA  ATP  ATP+KLA
 NM_031169 potassium large conductance calcium-activated channel, subfamily M, beta member 1 (Kcnmb1), mRNA [NM_031169] KLA .99 .97 .95 .99 .99 1.02 .95
ATP .95 1.04 .91 .95 .97 1.01 .98
KLA/ATP 1.11 .99 1.07 .94 .94 .90 .99
Kcnmb2
KLA  ATP  ATP+KLA
 NM_028231 potassium large conductance calcium-activated channel, subfamily M, beta member 2 (Kcnmb2), mRNA [NM_028231] KLA .99 1.06 1.04 1.09 .96 1.09 1.03
ATP .98 1.12 1.02 1.00 .98 1.07 1.06
KLA/ATP 1.06 .97 1.02 1.03 1.01 .98 1.06
Kcnmb4
KLA  ATP  ATP+KLA
 NM_021452 potassium large conductance calcium-activated channel, subfamily M, beta member 4 (Kcnmb4), mRNA [NM_021452] KLA 1.04 1.01 1.00 .95 1.04 1.01 .99
ATP .98 .94 1.12 1.03 1.00 1.00 1.01
KLA/ATP .99 1.06 .98 1.00 1.09 1.14 .98
Kcnu1
KLA  ATP  ATP+KLA
 NM_008432 potassium channel, subfamily U, member 1 (Kcnu1), mRNA [NM_008432] KLA .98 1.10 1.09 1.12 1.07 .98 1.07
ATP 1.09 1.10 1.10 1.05 .98 1.03 1.08
KLA/ATP 1.02 1.01 1.14 1.04 1.07 1.10 1.10
LOC10004
8021
KLA  ATP  ATP+KLA
 XM_001479354 ref|PREDICTED: Mus musculus similar to Guanine nucleotide-binding protein alpha-12 subunit (G alpha-12) (LOC100048021), mRNA [XM_001479354] KLA .29 .29 .23 .19 .25 .43 .47
ATP 1.03 1.08 .94 .88 .78 .52 .59
KLA/ATP .32 .29 .20 .22 .31 .47 .36
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Map2k2
KLA  ATP  ATP+KLA
 NM_023138 mitogen-activated protein kinase kinase 2 (Map2k2), mRNA [NM_023138] KLA .96 1.01 1.09 .99 1.11 1.15 1.42
ATP 1.07 1.05 .74 .86 1.04 1.16 1.21
KLA/ATP 1.14 1.03 .68 .78 .85 1.01 1.20
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mm.19961
KLA  ATP  ATP+KLA
 142378163 Unknown KLA 1.19 1.17 1.10 1.11 1.10 1.16 1.10
ATP .99 1.04 1.13 1.13 1.02 1.06 1.00
KLA/ATP 1.27 1.24 1.25 1.24 1.19 1.08 1.09
Mm.22094
6
KLA  ATP  ATP+KLA
 27545180 Unknown KLA 1.00 .93 .97 1.05 1.06 1.29 1.13
ATP .90 .94 1.25 1.18 .85 .62 1.20
KLA/ATP .86 .99 1.14 .99 .83 .70 1.26
Mm.25070
5
KLA  ATP  ATP+KLA
 7305294 Unknown KLA 1.01 1.06 1.00 1.05 .99 1.07 .99
ATP 1.00 1.05 1.06 1.03 .89 1.01 1.10
KLA/ATP 1.04 .92 1.05 1.07 1.00 1.00 1.05
Mm.28757
2
KLA  ATP  ATP+KLA
 163965437 Unknown KLA .78 .80 1.02 1.85 2.49 1.68 2.10
ATP .83 .79 1.13 .86 3.55 6.26 1.82
KLA/ATP .69 .68 .88 1.30 16.81 15.38 3.29
Mm.29825
6
KLA  ATP  ATP+KLA
 71361672 Unknown KLA .92 .90 .93 .90 .86 .80 .59
ATP .98 .96 1.01 .97 .83 .81 .57
KLA/ATP .77 .82 .81 .91 .84 .81 .61
Mm.33050
7
KLA  ATP  ATP+KLA
 67906182 Unknown KLA .94 .98 .99 1.03 1.05 1.07 .98
ATP .95 1.02 .97 .98 .99 1.05 1.02
KLA/ATP 1.02 1.05 1.01 1.03 .99 .98 .97
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Mm.44829
2
KLA  ATP  ATP+KLA
 86198313 Unknown KLA 1.12 1.03 1.02 1.14 1.04 1.07 1.02
ATP .95 .98 1.18 1.06 1.12 1.07 1.04
KLA/ATP 1.04 1.15 1.29 1.11 1.16 1.21 1.14
Mm.45157
8
KLA  ATP  ATP+KLA
 124486802 Unknown KLA .91 1.00 .99 .96 1.05 .99 1.02
ATP .96 1.06 1.02 .95 1.02 1.02 .97
KLA/ATP 1.06 1.00 1.04 1.01 .97 .94 1.05
Mm.46661
0
KLA  ATP  ATP+KLA
 82894546 Unknown KLA .86 .90 .99 .94 1.02 .83 .91
ATP 1.10 1.04 1.04 1.15 1.03 .93 .84
KLA/ATP .86 .85 1.00 1.10 .94 .85 .90
Mm.47526
5
KLA  ATP  ATP+KLA
 145046272 Unknown KLA 1.05 .97 .80 .91 .84 .88 .82
ATP .96 .81 1.14 .73 .64 1.00 .85
KLA/ATP .91 .89 .98 .66 .67 .78 .64
Mm.71913
KLA  ATP  ATP+KLA
 118130231 Unknown KLA .93 1.00 1.06 .97 .95 .98 1.04
ATP 1.00 .98 1.08 1.02 .92 .90 .99
KLA/ATP .99 1.01 1.00 .99 .99 .99 1.01
Mrvi1
KLA  ATP  ATP+KLA
 NM_194464 MRV integration site 1 (Mrvi1), transcript variant 2, mRNA [NM_194464] KLA .83 .86 .85 .90 .89 .82 .69
ATP 1.00 .98 .98 1.00 .84 .82 .75
KLA/ATP .92 .83 .91 .94 .89 .84 .66
Myh11
KLA  ATP  ATP+KLA
 NM_013607 myosin, heavy polypeptide 11, smooth muscle (Myh11), mRNA [NM_013607] KLA 1.01 1.05 1.02 1.06 1.00 .96 1.01
ATP 1.09 .98 1.00 1.00 1.03 .97 1.13
KLA/ATP .99 1.06 1.05 1.03 .98 1.05 1.10
Myl6
KLA  ATP  ATP+KLA
 NM_010860 myosin, light polypeptide 6, alkali, smooth muscle and non-muscle (Myl6), mRNA [NM_010860] KLA .85 .88 .84 .84 .92 1.00 .98
ATP .95 .92 .91 .88 .91 .94 .95
KLA/ATP .85 .81 .86 .82 .93 .89 .90
Myl6b
KLA  ATP  ATP+KLA
 AK017625 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730437E04 product:unclassifiable, full insert sequence [AK017625] KLA .86 .75 .86 .92 1.10 .88 .76
ATP .71 .51 .56 .56 .69 .92 .82
KLA/ATP .77 .56 .67 .69 1.06 .96 .90
Myl6b
KLA  ATP  ATP+KLA
 NM_172259 myosin, light polypeptide 6B (Myl6b), mRNA [NM_172259] KLA .98 1.04 .97 .97 .97 1.11 1.04
ATP .97 .99 1.00 .91 .97 1.06 1.03
KLA/ATP 1.00 .97 1.02 .98 1.04 .97 .99
Mylk
KLA  ATP  ATP+KLA
 AK044527 adult retina cDNA, RIKEN full-length enriched library, clone:A930019C19 product:MYOSIN LIGHT CHAIN KINASE (FRAGMENT) homolog [Mus musculus], full insert sequence. [AK044527] KLA 1.10 .99 .93 1.01 1.00 1.07 1.01
ATP 1.02 .97 .92 .99 1.02 .97 1.06
KLA/ATP 1.01 1.03 1.05 .97 .91 1.00 .96
Mylk
KLA  ATP  ATP+KLA
 NM_139300 myosin, light polypeptide kinase (Mylk), mRNA [NM_139300] KLA 1.05 1.15 1.22 1.24 1.33 1.21 .50
ATP 1.05 1.08 .96 .91 .79 .71 .40
KLA/ATP 1.14 1.18 1.15 1.04 .90 .79 .48
Mylk2
KLA  ATP  ATP+KLA
 NM_001081044 myosin, light polypeptide kinase 2, skeletal muscle (Mylk2), mRNA [NM_001081044] KLA 1.17 1.21 1.11 1.25 1.17 1.10 1.06
ATP .94 1.05 1.06 1.10 1.33 1.33 1.27
KLA/ATP 1.15 1.25 1.14 1.21 1.32 1.29 1.45
Mylk3
KLA  ATP  ATP+KLA
 AK052858 16 days neonate heart cDNA, RIKEN full-length enriched library, clone:D830007F02 product:Weakly similar to myosin light chain kinase, full insert sequence. [AK052858] KLA 1.06 1.02 .95 .98 1.01 1.04 1.02
ATP 1.02 1.06 1.00 1.01 .97 1.01 .98
KLA/ATP 1.08 1.00 .94 1.13 1.07 1.08 1.05
Nppa
KLA  ATP  ATP+KLA
 NM_008725 natriuretic peptide precursor type A (Nppa), mRNA [NM_008725] KLA 1.12 1.09 1.12 1.12 1.09 1.10 1.14
ATP 1.00 1.01 1.06 1.05 1.05 1.09 1.12
KLA/ATP 1.16 1.17 1.18 1.11 1.12 1.06 1.11
Nppb
KLA  ATP  ATP+KLA
 NM_008726 natriuretic peptide precursor type B (Nppb), mRNA [NM_008726] KLA 1.00 .98 .98 1.01 1.01 1.03 1.09
ATP .96 .95 .99 1.02 1.06 .99 1.18
KLA/ATP .94 .99 1.02 1.01 1.00 1.01 1.24
Nppc
KLA  ATP  ATP+KLA
 NM_010933 natriuretic peptide precursor type C (Nppc), mRNA [NM_010933] KLA 1.05 1.02 .99 1.04 1.02 .96 .97
ATP 1.00 .96 1.03 1.06 1.03 1.04 1.04
KLA/ATP 1.01 .99 1.07 .99 .96 1.06 1.03
Npr1
KLA  ATP  ATP+KLA
 NM_008727 natriuretic peptide receptor 1 (Npr1), mRNA [NM_008727] KLA 1.01 .99 .99 1.06 1.12 .99 1.05
ATP .99 .95 .99 1.01 .96 1.02 1.07
KLA/ATP 1.03 1.05 .99 1.03 1.07 .99 1.03
Npr2
KLA  ATP  ATP+KLA
 NM_173788 natriuretic peptide receptor 2 (Npr2), mRNA [NM_173788] KLA 1.09 1.04 1.09 1.17 1.10 1.02 .94
ATP 1.00 .99 1.10 1.10 1.11 1.08 .90
KLA/ATP 1.07 1.06 1.39 1.16 1.19 1.08 1.00
Pla2g10
KLA  ATP  ATP+KLA
 NM_011987 phospholipase A2, group X (Pla2g10), mRNA [NM_011987] KLA .99 1.11 1.02 .99 1.00 1.01 1.02
ATP 1.02 .97 1.01 1.03 1.00 1.02 1.04
KLA/ATP 1.04 .96 .95 1.04 1.06 1.05 1.01
Pla2g12a
KLA  ATP  ATP+KLA
 NM_023196 phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] KLA 1.03 1.06 .97 1.00 .78 .75 .92
ATP .91 .99 1.29 1.30 1.20 1.48 1.71
KLA/ATP .92 .99 1.19 1.16 1.06 1.12 1.36
Pla2g12a
KLA  ATP  ATP+KLA
 NM_183423 phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] KLA .90 1.00 .87 .95 .76 .68 .88
ATP .96 .94 1.26 1.24 1.19 1.47 1.88
KLA/ATP .89 .90 1.08 1.07 1.06 1.02 1.59
Pla2g12b
KLA  ATP  ATP+KLA
 NM_023530 phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] KLA .98 .95 1.05 .99 1.03 .99 .94
ATP 1.02 1.04 1.07 1.05 .92 1.04 1.00
KLA/ATP .98 .92 1.10 1.11 1.09 1.03 1.04
Pla2g1b
KLA  ATP  ATP+KLA
 NM_011107 phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] KLA 1.00 1.01 1.01 1.11 1.00 1.28 1.00
ATP .98 1.03 1.09 1.03 1.01 1.02 1.04
KLA/ATP .93 .94 1.01 1.00 .94 1.09 1.07
Pla2g2a
KLA  ATP  ATP+KLA
 NM_001082531 phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] KLA 1.08 .99 1.00 1.06 .98 1.01 .94
ATP 1.07 .98 1.04 1.06 .90 .98 .98
KLA/ATP .98 1.03 1.00 1.04 .94 .97 .96
Pla2g2c
KLA  ATP  ATP+KLA
 NM_008868 phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] KLA .98 .99 1.05 .98 1.01 1.00 1.04
ATP 1.08 1.06 1.09 .93 .92 .92 1.00
KLA/ATP 1.03 1.04 1.02 1.04 .98 1.01 1.02
Pla2g2d
KLA  ATP  ATP+KLA
 NM_011109 phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] KLA 1.02 1.02 .99 .99 1.00 1.01 1.00
ATP .95 1.11 1.10 1.11 .98 .99 1.12
KLA/ATP 1.02 1.00 1.19 1.11 1.00 .96 1.01
Pla2g2e
KLA  ATP  ATP+KLA
 NM_012044 phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] KLA .78 .75 .74 .72 .62 .69 1.40
ATP 1.06 1.00 .92 1.04 .83 .76 3.74
KLA/ATP .78 .80 .69 .74 .70 .74 2.24
Pla2g2f
KLA  ATP  ATP+KLA
 NM_012045 phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] KLA 1.02 .99 1.03 1.01 1.00 .95 .99
ATP 1.01 1.06 1.11 .97 1.09 1.11 .99
KLA/ATP 1.10 1.05 1.04 .95 1.04 1.01 .96
Pla2g3
KLA  ATP  ATP+KLA
 NM_172791 phospholipase A2, group III (Pla2g3), mRNA [NM_172791] KLA 1.04 1.05 1.02 1.01 1.04 1.11 1.00
ATP .96 .97 1.10 .91 .99 .97 1.08
KLA/ATP 1.03 1.11 1.10 .98 .95 .98 1.07
Pla2g4a
KLA  ATP  ATP+KLA
 NM_008869 phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] KLA 3.93 4.49 4.86 6.40 6.44 3.10 1.68
ATP 1.13 1.36 1.27 1.30 1.02 5.37 1.47
KLA/ATP 3.64 4.45 4.76 7.11 2.96 4.08 2.60
Pla2g4b
KLA  ATP  ATP+KLA
 NM_145378 phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] KLA 1.09 1.18 .95 1.01 .97 .97 .77
ATP 1.05 1.14 1.28 .94 .88 1.18 .70
KLA/ATP 1.23 1.43 1.21 1.02 1.15 1.16 .78
Pla2g4c
KLA  ATP  ATP+KLA
 AK145339 1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] KLA 1.09 1.21 1.33 1.17 1.26 1.30 1.05
ATP .97 1.06 1.00 .98 .98 .98 1.05
KLA/ATP 1.19 1.16 1.18 1.13 1.04 1.02 1.06
Pla2g4c
KLA  ATP  ATP+KLA
 NM_001004762 phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] KLA .93 1.00 .94 .93 .94 .94 .96
ATP .98 .96 1.13 .97 .99 .89 .96
KLA/ATP 1.01 1.01 1.07 1.01 .94 1.01 .92
Pla2g4e
KLA  ATP  ATP+KLA
 AK049063 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] KLA 1.03 1.09 1.01 1.01 1.06 .94 1.05
ATP 1.03 1.00 1.06 1.01 .96 1.05 1.05
KLA/ATP .98 1.00 1.01 .98 1.03 .95 1.01
Pla2g4e
KLA  ATP  ATP+KLA
 NM_177845 phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] KLA .97 .95 1.01 .97 1.02 1.03 1.05
ATP .98 .99 1.00 1.10 .98 1.00 1.02
KLA/ATP 1.05 .93 .96 1.03 1.08 1.05 .99
Pla2g4f
KLA  ATP  ATP+KLA
 NM_001024145 phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] KLA 1.08 .99 1.04 1.02 1.04 .98 1.01
ATP .99 1.04 .99 1.03 1.12 1.01 1.25
KLA/ATP .97 1.04 1.10 1.06 1.04 1.03 1.03
Pla2g5
KLA  ATP  ATP+KLA
 NM_011110 phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] KLA .65 .62 .56 .53 .62 1.60 3.01
ATP .90 .82 .88 1.69 1.82 1.26 6.32
KLA/ATP .63 .59 .65 .63 .91 1.56 5.59
Pla2g6
KLA  ATP  ATP+KLA
 NM_016915 phospholipase A2, group VI (Pla2g6), mRNA [NM_016915] KLA .60 .59 .56 .60 .94 1.31 1.59
ATP 1.10 1.14 .95 1.05 1.06 1.13 1.14
KLA/ATP .63 .56 .54 .56 .71 .97 1.55
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Ppp1ca
KLA  ATP  ATP+KLA
 NM_031868 protein phosphatase 1, catalytic subunit, alpha isoform (Ppp1ca), mRNA [NM_031868] KLA .89 .93 .93 .86 .95 1.07 1.20
ATP 1.04 1.07 .93 1.02 1.01 .89 1.10
KLA/ATP .98 .93 .74 .91 .84 1.01 1.34
Ppp1cb
KLA  ATP  ATP+KLA
 NM_172707 protein phosphatase 1, catalytic subunit, beta isoform (Ppp1cb), mRNA [NM_172707] KLA 1.12 1.08 1.05 1.02 .89 .84 .94
ATP .89 .87 .75 .55 .73 1.14 .69
KLA/ATP .92 .94 .80 .64 .64 .83 .65
Ppp1cc
KLA  ATP  ATP+KLA
 NM_013636 protein phosphatase 1, catalytic subunit, gamma isoform (Ppp1cc), mRNA [NM_013636] KLA .51 .51 .49 .48 .53 .64 .64
ATP 1.02 1.01 .85 .79 .72 .89 .95
KLA/ATP .54 .49 .42 .43 .56 .76 .81
Ppp1r12a
KLA  ATP  ATP+KLA
 AK077739 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730577I22 product:inferred: myosin phosphatase, target subunit 1, full insert sequence [AK077739] KLA 1.91 1.98 2.00 2.00 1.63 1.58 1.17
ATP .93 .80 .82 .46 1.01 1.29 .79
KLA/ATP 1.82 1.80 1.85 .91 1.54 1.51 .90
Ppp1r12a
KLA  ATP  ATP+KLA
 NM_027892 protein phosphatase 1, regulatory (inhibitor) subunit 12A (Ppp1r12a), mRNA [NM_027892] KLA 2.36 2.42 2.34 2.71 1.96 2.11 1.93
ATP .87 .85 1.00 .98 1.75 4.57 2.89
KLA/ATP 2.02 2.24 2.59 1.90 2.16 4.01 5.77
Ppp1r12b
KLA  ATP  ATP+KLA
 AK132310 15 days embryo head cDNA, RIKEN full-length enriched library, clone:4022402N03 product:unclassifiable, full insert sequence [AK132310] KLA .82 .86 .71 .94 1.26 1.84 5.38
ATP 1.02 1.07 1.17 1.23 1.24 1.58 1.53
KLA/ATP .83 .82 .82 .84 .80 1.51 3.05
Ppp1r12b
KLA  ATP  ATP+KLA
 NM_001081307 protein phosphatase 1, regulatory (inhibitor) subunit 12B (Ppp1r12b), mRNA [NM_001081307] KLA .78 .80 .80 .75 .85 .79 .91
ATP .87 .83 .89 .75 1.01 .88 1.04
KLA/ATP .74 .73 .78 .71 .88 .86 .89
Ppp1r14a
KLA  ATP  ATP+KLA
 NM_026731 protein phosphatase 1, regulatory (inhibitor) subunit 14A (Ppp1r14a), mRNA [NM_026731] KLA 1.13 1.23 1.19 1.03 1.10 1.03 .99
ATP 1.02 1.01 1.05 1.05 1.02 .99 1.04
KLA/ATP 1.16 1.19 1.14 1.14 1.09 1.02 1.04
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkcd
KLA  ATP  ATP+KLA
 NM_011103 protein kinase C, delta (Prkcd), mRNA [NM_011103] KLA 1.72 1.84 1.90 1.68 2.01 1.61 1.64
ATP 1.00 1.03 .68 .81 1.38 1.26 .98
KLA/ATP 1.77 1.79 1.16 1.19 1.33 1.25 1.56
Prkce
KLA  ATP  ATP+KLA
 AK017901 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830406C15 product:unclassifiable, full insert sequence. [AK017901] KLA 1.63 1.44 1.95 2.09 1.96 1.34 1.56
ATP .99 .83 .85 .78 .85 2.44 1.47
KLA/ATP 1.36 1.45 1.44 1.23 1.30 2.39 2.29
Prkce
KLA  ATP  ATP+KLA
 AK042994 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730046G04 product:protein kinase C, epsilon, full insert sequence. [AK042994] KLA 1.01 1.07 1.03 1.03 1.04 1.00 1.06
ATP .99 1.09 1.08 1.05 1.02 1.06 1.07
KLA/ATP 1.00 .90 1.06 1.14 1.10 1.08 1.09
Prkch
KLA  ATP  ATP+KLA
 NM_008856 protein kinase C, eta (Prkch), mRNA [NM_008856] KLA .17 .14 .13 .19 .37 .78 .87
ATP 1.01 1.09 1.00 1.02 .46 .29 .78
KLA/ATP .16 .14 .15 .19 .20 .26 .87
Prkcq
KLA  ATP  ATP+KLA
 AK085546 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630039J01 product:protein kinase C, theta, full insert sequence [AK085546] KLA .98 .99 1.01 1.00 .95 .98 .97
ATP 1.06 .98 1.02 1.00 .99 .99 1.04
KLA/ATP .91 1.01 .84 1.02 1.03 1.00 1.03
Prkcq
KLA  ATP  ATP+KLA
 NM_008859 protein kinase C, theta (Prkcq), mRNA [NM_008859] KLA 1.04 1.07 1.00 1.06 1.02 .91 .87
ATP 1.06 .97 .97 .99 .94 1.00 .89
KLA/ATP 1.09 1.00 1.15 1.14 .98 1.07 .96
Prkg1
KLA  ATP  ATP+KLA
 NM_011160 protein kinase, cGMP-dependent, type I (Prkg1), transcript variant 2, mRNA [NM_011160] KLA .97 .96 .97 1.08 1.11 .93 .94
ATP 1.07 .96 .94 .99 1.03 1.60 .90
KLA/ATP .95 1.07 1.00 1.04 1.00 1.04 .91
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Ptgir
KLA  ATP  ATP+KLA
 NM_008967 prostaglandin I receptor (IP) (Ptgir), mRNA [NM_008967] KLA .89 .94 1.08 1.86 2.47 1.66 2.03
ATP .98 .92 1.09 .96 3.20 5.46 1.68
KLA/ATP .83 .83 1.03 1.43 12.77 10.57 2.80
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
Ramp1
KLA  ATP  ATP+KLA
 NM_016894 receptor (calcitonin) activity modifying protein 1 (Ramp1), transcript variant 1, mRNA [NM_016894] KLA .92 .95 .94 .91 .81 .66 .37
ATP 1.08 1.27 1.13 1.23 .93 .69 .37
KLA/ATP .93 1.00 1.06 1.00 .75 .66 .44
Ramp2
KLA  ATP  ATP+KLA
 NM_019444 receptor (calcitonin) activity modifying protein 2 (Ramp2), mRNA [NM_019444] KLA .87 .85 .81 .88 .83 .76 .58
ATP .89 1.00 1.12 .94 .88 .79 .57
KLA/ATP .81 .78 .85 .84 .86 .76 .61
Ramp3
KLA  ATP  ATP+KLA
 NM_019511 receptor (calcitonin) activity modifying protein 3 (Ramp3), mRNA [NM_019511] KLA 1.14 1.12 1.09 1.10 1.15 1.20 1.15
ATP 1.03 .97 1.56 1.96 2.38 4.57 4.77
KLA/ATP 1.12 1.24 1.44 2.10 2.83 5.40 8.36
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Rock1
KLA  ATP  ATP+KLA
 NM_009071 Rho-associated coiled-coil containing protein kinase 1 (Rock1), mRNA [NM_009071] KLA 2.40 2.48 2.37 3.07 1.94 1.42 1.21
ATP .95 .92 .87 .70 1.13 1.74 .98
KLA/ATP 2.27 2.35 2.56 1.60 1.65 1.56 1.23
Rock2
KLA  ATP  ATP+KLA
 NM_009072 Rho-associated coiled-coil containing protein kinase 2 (Rock2), mRNA [NM_009072] KLA .99 .92 .83 .87 .73 .74 1.04
ATP 1.07 1.31 1.16 1.02 1.02 1.03 .88
KLA/ATP 1.00 1.07 .93 .85 .69 .63 .81